Abituzumab (DI17E6) is a humanized monoclonal antibody of the IgG2 subtype that targets integrin ??V. It effectively inhibits the phosphorylation of focal adhesion kinase (FAK), Akt, and extracellular signal-regulated kinase (ERK), key signaling molecules involved in cell migration and survival. This antibody is particularly useful in cancer research applications, with a focus on studies related to prostate cancer. Abituzumab's precise targeting of integrin ??V makes it a valuable tool for investigating the role of this integrin in tumor progression and metastasis.
Abituzumab (DI17E6) is a humanized monoclonal antibody of the IgG2 subtype that targets integrin ??V. It effectively inhibits the phosphorylation of focal adhesion kinase (FAK), Akt, and extracellular signal-regulated kinase (ERK), key signaling molecules involved in cell migration and survival. This antibody is particularly useful in cancer research applications, with a focus on studies related to prostate cancer. Abituzumab's precise targeting of integrin ??V makes it a valuable tool for investigating the role of this integrin in tumor progression and metastasis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
